Paul Aisen

机构：University of Southern California, Brigham and Women's Hospital, Autism Research Institute, Mayo Clinic in Arizona, Southern States University

发表论文 414 篇 · 总被引 66632 次 · h-index 101

代表论文

The case for regulatory approval of amyloid‐lowering immunotherapies in Alzheimer's disease based on clearcut biomarker evidence (2024 · Alzheimer s & Dementia · 被引 30)
Multi-organ metabolome biological age implicates cardiometabolic conditions and mortality risk (2025 · Nature Communications · 被引 25)
Concurrent Changes in Plasma Phosphorylated Tau 217, Tau PET, and Cognition in Preclinical Alzheimer Disease (2025 · JAMA Neurology · 被引 23)
Defining benefit: Clinically and biologically meaningful outcomes in the next‐generation Alzheimer's disease clinical care pathway (2024 · Alzheimer s & Dementia · 被引 18)
Deep learning to quantify the pace of brain aging in relation to neurocognitive changes (2025 · Proceedings of the National Academy of Sciences · 被引 15)
Amyloid PET in Sporadic Early‐ Versus Late‐Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts (2025 · Annals of Neurology · 被引 11)